IRVINE, Calif. & BOONE, N.C.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) and Appalachian Regional Healthcare System announced that Watauga Medical Center in Boone is the first hospital in North Carolina to install Masimo Patient SafetyNet, a remote monitoring and clinician notification system, and Radius-7, a patient-worn monitor that is designed to allow for patient mobility along with continuous monitoring.
“We are always looking for cutting-edge technologies focused on patient safety,” said Richard Sparks, President & CEO, Appalachian Regional Healthcare System. “We wanted a system that provides continuous monitoring that wasn’t restricted to the patient’s room. The Radius-7 combined with Patient SafetyNet allows us the ability to keep a close eye on our patients 24/7.”
Continuous patient surveillance with Patient SafetyNet has been shown to reduce the need for rescue events and intensive care unit transfers in hospitals and, as a result, can reduce costs related to these events.1,2 When changes occur in the measured values, which may indicate deterioration in the patient’s condition, in addition to bedside alerts, the alert also shows in the Telemetry room and nurse’s stations. This allows the telemetry technician to contact the unit where the alarm is happening immediately. Masimo Patient SafetyNet works in conjunction with Masimo beside monitors and the Radius-7 wearable monitor to provide wireless, continuous and non-invasive monitoring of oxygenation, pulse rate and respiration, among other parameters.
Appalachian Regional Healthcare System’s Charles A. Cannon, Jr. Memorial Hospital also recently implemented continuous monitoring. At this location, the monitors are connected to the patient call system. When an alert goes off, it sounds through the call lights and then sends a message to the nurse’s station call monitor.
“Watauga Medical Center in Boone and Cannon Memorial Hospital in Linville understand the importance of patient safety,” said Joe Kiani, Founder and CEO of Masimo. “We are excited to see more and more hospitals implement continuous monitoring of their patients in post-surgical wards, as part of their patient safety protocols.”
@MasimoInnovates | #Masimo
1 Taenzer A.H., Pyke J.B., McGrath S.P., Blike G.T. Anesthesiology.
2010 Feb; 112(2):282-7.
2 Taenzer A, Blike G, McGrath S, Pyke J, Herrick M, Renaud C, Morgan J. “Postoperative Monitoring - The Dartmouth Experience.” Anesthesia Patient Safety Foundation Newsletter Spring-Summer 2012. Available online.
About Appalachian Regional Healthcare System
Appalachian Regional Healthcare System (ARHS), the healthcare leader in the High Country, is comprised of two hospitals - Charles A. Cannon, Jr. Memorial Hospital in Linville and Watauga Medical Center in Boone - a physician practice management group - Appalachian Regional Medical Associates (ARMA) - the Blowing Rock Rehabilitation & Davant Extended Care Center in Blowing Rock - and Appalachian Regional Healthcare Foundation. Appalachian Regional Healthcare System stays committed to promoting health in the High Country, enhancing quality of life and simply “making life better.” This charge makes Appalachian Regional Healthcare System the premier healthcare system in this region. For more information, visit www.apprhs.org.
Masimo (NASDAQ: MASI) is a global leader in innovative noninvasive monitoring technologies. Our mission is to improve patient outcomes and reduce the cost of care by taking noninvasive monitoring to new sites and applications. In 1995, the company debuted Masimo SET® Measure-through Motion and Low Perfusion™ pulse oximetry, which has been shown in multiple studies to significantly reduce false alarms and accurately monitor for true alarms. The benefits of Masimo SET® have been proven in more than 100 independent and objective studies and it is estimated to be used on more than 100 million patients in leading hospitals and other healthcare settings around the world. In 2005, Masimo introduced rainbow® Pulse CO-Oximetry technology, allowing noninvasive and continuous monitoring of blood constituents that previously could only be measured invasively, including total hemoglobin (SpHb®), oxygen content (SpOC™), carboxyhemoglobin (SpCO®), methemoglobin (SpMet®), and more recently, Pleth Variability Index (PVI®) and Oxygen Reserve Index (ORI™), in addition to SpO2, pulse rate, and perfusion index (PI). In 2014, Masimo introduced Root®, an intuitive patient monitoring and connectivity platform designed to speed the pace of innovation and reduce the cost of care. Masimo is also taking an active leadership role in mHealth with products such as the MightySat™ fingertip pulse oximeter. Additional information about Masimo and its products may be found at www.masimo.com.
This press release includes forward-looking statements as defined in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, in connection with the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on current expectations about future events affecting us and are subject to risks and uncertainties, all of which are difficult to predict and many of which are beyond our control and could cause our actual results to differ materially and adversely from those expressed in our forward-looking statements as a result of various risk factors, including, but not limited to: risks related to our belief that Masimo's unique noninvasive measurement technologies contribute to positive clinical outcomes and patient safety; risks related to our belief that Masimo noninvasive medical breakthroughs provide cost-effective solutions with comparable accuracy and unique advantages; as well as other factors discussed in the "Risk Factors" section of our most recent reports filed with the Securities and Exchange Commission ("SEC"), which may be obtained for free at the SEC's website at www.sec.gov. Although we believe that the expectations reflected in our forward-looking statements are reasonable, we do not know whether our expectations will prove correct. All forward-looking statements included in this press release are expressly qualified in their entirety by the foregoing cautionary statements. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of today's date. We do not undertake any obligation to update, amend or clarify these statements or the "Risk Factors" contained in our most recent reports filed with the SEC, whether as a result of new information, future events or otherwise, except as may be required under the applicable securities laws.